<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127928">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02135575</url>
  </required_header>
  <id_info>
    <org_study_id>CWS-WP2CV</org_study_id>
    <nct_id>NCT02135575</nct_id>
  </id_info>
  <brief_title>Effects of Exercise Training on Cardiovascular Health in Middle-aged Women</brief_title>
  <official_title>Effects of Exercise Training on Cardiovascular Health in Middle-aged Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the present study is that physical training can oppose detrimental changes
      in cardiovascular and metabolic health associated with estrogen loss after menopause.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Leg vascular function</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measurements of leg blood flow by ultrasound doppler during exercise and during femoral arterial infusion of vasodilators</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac structure and function</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Magnetic resonance imaging and transthoracic echocardiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet function</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Platelet aggregation assay of whole blood and platelet rich plasma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Expression of proteins in muscle samples</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Western Blot analysis of proteins of relevance for vascular function and metabolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal aerobic effect</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Maximal oxygen uptake during an incremental cycle ergometry test with gas analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genomic profile in blood samples</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Genomic analysis of parameters for vascular and metabolic health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity and glycaemic control</measure>
    <time_frame>Base-line comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Fasting plasma glucose analysis and oral glucose tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood pressure</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gene expression of proteins in muscle samples</measure>
    <time_frame>Changes from base-line to 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Gene analysis of relevance for vascular and metabolic function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related parameters in blood</measure>
    <time_frame>Changes from baseline to 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Plasma lipid status and other variables related to vascular health</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Anthropometry</measure>
    <time_frame>Baseline comparison and changes at 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Dual x-ray absorptiometry, height, weight, waist and hip circumference</description>
  </other_outcome>
  <other_outcome>
    <measure>Activity measure</measure>
    <time_frame>Pre, 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Activity measure for one week by accelerometer</description>
  </other_outcome>
  <other_outcome>
    <measure>Food registration</measure>
    <time_frame>Pre, 3 and 10 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Food registration by questionnaire for 4 days in a week</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Menopause</condition>
  <condition>Cardiac Function Impaired</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Blood Platelet Disorders</condition>
  <condition>Metabolic Diseases</condition>
  <arm_group>
    <arm_group_label>Premenopausal women</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The premenopausal women are tested at base-line</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Postmenopausal women</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Postmenopausal women are randomized to either exercise by spinning (cycle) or yoga/pilates</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Yoga/Pilates</intervention_name>
    <description>Behavioral: Yoga/PilatesAfter the baseline studies the postmenopausal women will be randomized to two different training groups and the intervention will last for 10 months, The yoga/pilates group will do Yoga/Pilates twice per week. The sessions are performed by a trained instructor. Some sessions are heart rate monitored.</description>
    <arm_group_label>Postmenopausal women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Spinning</intervention_name>
    <description>After the baseline studies the postmenopausal women will be randomized to two different training groups and the intervention will last for 10 months. The spinning group will spin three times per week under guidance of a trained instructor. The training is heart rate monitored.</description>
    <arm_group_label>Postmenopausal women</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premenopausal (45-53 years) OR postmenopausal 50-57 years

          -  BMI&gt; 18.5 and &lt;30

          -  Sedentary (no regular physical activity the last 2 years)

          -  Plasma measurements

          -  Premenopausal: estradiol&gt; 0.20 nmol/l, Follicle stimulating hormone &lt; 22 IU/l and
             progesterone &gt;2.5 nmol/l

          -  Postmenopausal: estradiol &lt; 0.20 nmol/l, Follicle stimulating hormone &gt; 22 IU/l and
             progesterone 0.3-2.5  nmol/l

        Exclusion Criteria:

          -  Smoking

          -  Excessive alcohol intake

          -  Regular medication including hormone replacement treatment

          -  Chronic disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>57 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Michael Nyberg, PhD</last_name>
    <phone>35321622</phone>
    <email>mnyberg@ifi.ku.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ylva Hellsten, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>April 1, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Copenhagen</investigator_affiliation>
    <investigator_full_name>Ylva Hellsten</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>premenopausal</keyword>
  <keyword>postmenopausal</keyword>
  <keyword>cardiovascular</keyword>
  <keyword>exercise training</keyword>
  <keyword>vascular function</keyword>
  <keyword>cardiac function</keyword>
  <keyword>cardiac morphology</keyword>
  <keyword>health</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Blood Platelet Disorders</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
